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Abstract
Background: The present study was designed to investigate the antibacterial activities of the methanol extract of
three edible plants, namely Xanthosoma mafaffa, Moringa oleifera and Passiflora edulis and their synergistic effects
with some commonly used antibiotics against MDR Gram-negative bacteria expressing active efflux pumps.
Methods: Broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) and
the minimum bactericidal concentrations (MBCs) of the extracts, as well as those of antibiotics in association with
the extracts.
Results: The phytochemical test indicate that all tested crude extracts contained polyphenols, triterpenes and steroids
whilst other phytochemical classes were selectively distributed. Extracts showed antibacterial activities with minimum
inhibitory concentrations ranging from 128-1024 μg/mL on the majority of the 19 tested Gram-negative bacterial strains.
Extract from the pericarp of P. edulis inhibited the growth of 89.5 % of the 19 tested bacterial strains, the lowest minimal
inhibitory concentration (MIC) value of 128 μg/mL being recorded against Escherichia coli AG100 strain. In the presence of
Phenylalanine-Arginine β-Naphtylamide (PAβN)], an efflux pump inhibitor (EPI), the activity of the extract from X. mafaffa
increased on 40 % of tested strains. In combination with antibiotics, extracts of X. mafaffa, M. oleifera and pericarp of P.
edulis showed synergistic effects with some antibiotics against more than 75 % of the tested bacteria.
Conclusion: The results of the present study indicate that the tested plants may be used in the treatment of bacterial
infections including the multi-resistant bacteria.
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Background
Infectious diseases remain the major cause of mortality
amongst children and young adults worldwide, with
higher prevalence in developing countries [1]. Despite
the abundance of antibiotics used in chemotherapy,
there is a drastic increase of resistant bacteria. Resistance
to antibiotics occurs typically as a result of drug inacti-
vation or modification, target alteration, or reduced ac-
cumulation associated with decreased permeability and⁄
or increased efflux [2]. The scarcity of new antimicro-
bials active against MDR bacteria propels the search of
chemotherapeutic agents. While 25–50 % of current
pharmaceuticals are derived from natural products, it
was reported that none are used as antimicrobials [3].
Investigation of substances which can potentiate the
activity of commonly used antibiotics are also being in-
tensified [4–7]. Previous studies documented the good
antimicrobial potential of natural products from higher
plants [8, 9]. Several food plants were also documented
as potential candidate to fight MDR Gram-negative bac-
teria. Some of them include Dichrostachys glomerata,
Beilschmiedia cinnamomea, Aframomum citratum, Piper
capense, Echinops giganteus, Fagara xanthoxyloïdes and
Olax subscorpioïdea [4], Lactuca sativa, Sechium edule,
Cucurbita pepo and Solanum nigrum [10], Piper nigrum
and Vernonia amygdalina [11], Beilschmiedia obscura,
Pachypodanthium staudtii and Peperomia fernandopoi-
ana [12], Capsicum frutescens [13]. In our continous
search of functional food plants, we designed the present
work to investigate in vitro antibacterial activity of the
methanol extracts of three Cameroonian food plants,
Moringa oleifera Lam. (Moringaceae), Xanthosoma
mafaffa (L.) Schott (Araceae), Passiflora edulis Sims
(Passifloraceae) against MDR bacteria. The study was ex-
tended to the ability of the studied extracts to potentiate
the activity of some commonly used antibiotics against
some of the tested MDR bacteria.
Methods
Plant material and extraction
The three food plants used in this work were purchased
from the Bafoussam markets (West Region of
Cameroon) in January 2014. The collected plant material
were the leaves of Xanthosoma mafaffa, Moringa oleifera
and the fruits of Passiflora edulis. The plants were iden-
tified at the National herbarium (Yaounde, Cameroon)
where voucher specimens were deposited under the ref-
erence numbers (Table 1). Each plant sample was air
dried and then powdered. The obtained powder (200 g)
was extracted with methanol (MeOH; 1 L) for 48 h at
room temperature with momentary shaking. Methanol
was then removed under reduced pressure to give resi-
dues which constituted the crude extract. All extracts
were then kept at 4 °C until further use.
Preliminary phytochemical screening
The major phytochemical classes such as alkaloids
(Dragendorff ’s and Mayer’s tests), triterpenes (Libermann
Burchard’s test), flavonoids (Aluminum chloride test),
anthraquinones (Borntrager’s test), polyphenols (Ferric
chloride test), sterols (Salkowski’s test), coumarins (Lacton
test), saponins (Foam test) and tannins (Gelatin test)
(Table 2) were investigated according to the commonly
described phytochemical methods [14–17].
Antimicrobial assays
Chemicals for antimicrobial assay
Tetracycline (TET), cefepime (CEP), ciprofloxacin (CIP),
norfloxacin (NOR), chloramphenicol (CHL), ampicillin
(AMP), erythromycin (ERY), kanamycin (KAN) (Sigma-
Table 1 Information on plants used in the present study
Species (family);
Voucher numbera




























edulan-II, passifloric acid methyl ester [40]
Methanol extract : Sa, Sf,


















extracts of seeds against
Sa, Vc, Ec, Se, Lv and On [44]
a(HNC) Herbier National du Cameroun, (SRF/Cam) Société des Réserves Forestières du Cameroun; (-): nor reported; Sa: Staphylococcus aureus; Vc: Vibrio cholerae;
Ec: Escherichia coli; Se: Salmonella enteretidis; Lv: Litopenaeus vannmaei; On: Oreochromis nicoticus; Bs: Bacillus subtilis; St: Salmonella typhi; Sf: Streptococcus faecalis;
Pv: Proteus vulgaris; HIV-AIDS: Human Immunodeficiency Virus- Acquired Immuno Deficiency Syndrome
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Aldrich, St Quentin Fallavier, France) were used as refer-
ence antibiotics (RA). p-Iodonitrotetrazolium chloride
(INT; Sigma-Aldrich) and Phenylalanine-Arginine-ß-
Naphthylamide (PAßN; Sigma-Aldrich) were used as mi-
crobial growth indicator and efflux pumps inhibitor (EPI)
respectively [18, 19].
Microbial strains and culture media
The studied microorganisms included sensitive and re-
sistant strains of Escherichia coli (ATTC8739, AG100,
AG100A, AG102, AG100ATet, W3110), Enterobacter
aerogenes (ATCC13048, EA289, EA27, EA298, CM64),
Klebsiella pneumoniae (ATCC11296, KP55, KP63, K24),
Pseudomonas aeruginosa (PA01, PA124), Providencia
stuartii (ATCC29914, NEA16) obtained clinically or
from the American Type Culture Collection (ATCC).
Their resistance profiles have been previously reported
[7, 13, 20]. Nutrient agar were used for the activation of
the tested Gram-negative bacteria [21].
INT colorimetric assay for MIC and MBC determinations
The MIC determinations on the tested bacteria were
conducted using rapid p-iodonitrotetrazolium chloride
(INT) colorimetric assay according to described methods
[18] with some modifications [22, 23]. The test samples
and RA were first of all dissolved in DMSO/Mueller
Hinton Broth (MHB) or DMSO/7H9 broth. The final
concentration of DMSO was lower than 2.5 % and does
not affect the microbial growth [24, 25]. The solution
obtained was then added to Mueller Hinton Broth,
and serially diluted two fold (in a 96- wells micro-
plate). One hundred microlitre (100 μL) of inoculum









Yielda (%) 4.30 3.92 3.95
Alkaloids - - +
Polyphenols + + +
Flavonoids - + +
Anthraquinones - - +
Coumarins + - +
Tannins + - +
Triterpenes + + +
Sterols + + +
Saponins + + +
(-): Absent; (+): Present; ayield calculated as the ratio of the mass of the
obtained methanol extract/mass of the plant powder
Table 3 Minimal Inhibitory Concentration (MIC) in μg/mL of methanol extracts from the studied plants and chloramphenicol
Bacterial strains Tested samples, MIC and MBC and MIC in the presence of PAßN in parenthesis (μg/mL)
Xanthosoma mafaffa Passiflora edulis Moringa oleifera Chloramphenicol
MIC MBC R MIC MBC R MIC MBC R MIC MBC R
E. coli ATCC8739 - - - 256 - - 256 - - 4 - -
AG100 256 (512) - - 128 (<4) 1024 8 128 (256) - - 4 (<4) 256 64
AG100A 512 1024 2 512 1024 2 512 - - 2 64 32
AG102 1024 (512) - - 512 (1024) 1024 2 256 (1024) - - 8 (<4) - -
AG100ATet 256 (-) - - 1024 (-) - - 1024 (-) 1024 1 64 (32) 256 4
W3110 1024 - - 256 - - 256 - - 8 16 2
E. aerogenes ATCC13048 - - - 256 - - 1024 - - 8 128 16
EA289 512 (1024) - - 512 (1024) 1024 2 1024 (1024) - - 64 (32) 512 8
EA27 256 (16) - - 256 (16) - - 1024 (1024) - - 64 (<4) 512 8
EA298 - - - 512 - - - - - 32 256 8
CM64 - (-) - - - (-) - - - (-) - - 256 (4) 256 1
K. pneumoniae ATCC11296 256 - - 256 - - - - - 4 512 128
KP55 1024 (512) - - 512 (1024) - - 256 (1024) - - 64 (16) 128 2
KP63 1024 (512) - - 512 (1024) - - - (-) - - 256 (32) 256 1
K24 - - - 1024 - - - - - 64 256 4
P. aeruginosa PA01 - - - 256 - - 1024 - - 16 256 16
PA124 - (-) - - - (-) - - - (-) - - 64 (4) 512 8
P. stuartii ATCC29914 - - - 512 - - 1024 - - 8 32 4
NEA16 512 (1024) - - 256 (1024) - - 1024 (1024) - - 32 (4) 256 8
R: MIC/MBC; -: MIC > 1024 or not detected; (): values in parenthesis are MIC of substance in the presence of PAßN at 30 μg/mL
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1.5 x 106 CFU/mL prepared in appropriate broth was
then added [22, 23]. The plates were covered with a
sterile plate sealer, then agitated to mix the contents
of the wells using a plate shaker and incubated at
37 °C for 18 h. The assay was repeated thrice. Wells
containing adequate broth, 100 μL of inoculum and
DMSO to a final concentration of 2.5 % served as
negative control. The MIC of samples was detected
after 18 h incubation at 37 °C, following addition
(40 μL) of 0.2 mg/mL of INT and incubation at 37 °C
for 30 min. Viable bacteria reduced the yellow dye to
a pink. MIC was defined as the lowest sample con-
centration that prevented the color change of the
medium and exhibited complete inhibition of micro-
bial growth [18]. The MBC was determined by adding
50 μL aliquots of the preparations, which did not
show any growth after incubation during MIC assays,
to 150 μL of adequate broth. These preparations were
incubated at 37 °C for 48 h. The MBC was regarded
as the lowest concentration of extract, which did not
produce a color change after addition of INT as men-
tioned above [22, 23].
To evaluate the role of efflux pumps in the susceptibil-
ity of Gram-negative bacteria to Xanthosoma mafaffa,
Moringa oleifera and Passiflora edulis, crude extracts
were tested in the presence of PAßN (at 30 μg/mL)
against ten selected MDR phenotypes (E. coli AG100,
AG102 and AG100ATet, E. aerogenes EA289, EA27 and
CM64, K. pneumoniae KP55 and KP63, P. aeruginosa
PA124 and P. stuartii NAE16).
Extracts from Xanthosoma mafaffa, Moringa oleifera
and Passiflora edulis were also tested in association with
Table 4 MIC (FIC) of different antibiotics in association with the extract of Xanthosoma mafaffa at MIC/2, MIC/4 against ten MDR
bacteria strains
Antibiotics Bacterial strains, MIC (μg/mL) of antibiotics in the absence and presence of the extract
Extract
concentration
PA124 AG100 AG102 AG100Atet EA27 EA289 CM64 KP55 KP63 NEA16 PBSS
(%)
CIP 0 16 0.50 0.50 - 1 1 0.50 2 - 1
CMI/2 16(1)I 0.50(1)I <0.50(na)S -(na) 0.25(0.25)S 0.50(0.50)S 1(2)I <0.50(na)S 16(na)S 0.50(0.50)S 60
CMI/4 16(1)I 0.50(1)I <0.50(na)S -(na) 0.25(0.25)S 1(1)I 1(2)I <0.50(na)S 16(na)S 1(1)I 40
NOR 0 128 2 1 - 4 8 4 16 - 4
CMI/2 128(1)I 2(1)I <1(na)S 128(na)S 8(2)I 16(2)I 32(8)A 16(1)I 128(na)S 8(2)I 30
CMI/4 128(1)I 2(1)I <1(na)S 128(na)S 32(8)A 16(2)I 32(8)A 16(1)I -(na) 8(2)I 20
CHL 0 64 4 8 64 64 64 256 64 - 32
CMI/2 64(1)I 4(1)I 1(0.13)S 32(0.50)S 4(0.06)S 32(0.50)S 256(1)I 16(0.25)S -(na) 16(0.50)S 60
CMI/4 64(1)I 4(1)I 2(0.25)S 64(1)I 16(0.25)S 32(0.50)S 256(1)I 16(0.25)S -(na) 16(0.50)S 50
ERY 0 128 0.50 0.50 - 16 16 256 32 - 32
CMI/2 64(0.50)S <0.50(na)S <0.50(na)S 128(na)S 8(0.50)S 8(0.50)S 256(1)I 32(1)I 128(na)S 16(0.50)S 80
CMI/4 64(0.50)S <0.50(na)S <0.50(na)S 128(na)S 8(0.50)S 8(0.50)S 256(1)I 64(2)I 128(na)S 16(0.50)S 80
KAN 0 64 0.50 0.50 2 8 32 4 16 - 16
CMI/2 32(0.50)S <0.50(na)S <0.50(na)S <0.50(na)S 4(0.50)S 8(0.25)S 2(0.50)S 16(1)I -(na) 16(1)I 70
CMI/4 64(1)I <0.50(na)S 1(2)I 1(0.50)S 8(1)I 8(0.25)S 4(1)I 16(1)I -(na) 16(1)I 30
TET 0 16 32 2 64 32 32 8 2 8 32
CMI/2 8(0.50)S 16(0.50)S <0.50(na)S 4(0.06)S 8(0.25)S 4(0.13)S 2(0.25)S <0.50(na)S 1(0.13)S 4(0.13)S 100
CMI/4 16(1)I 32(1)I 1(0.50)S 4(0.06)S 8(0.25)S 16(0.50)S 2(0.25)S <0.50(na)S 1(0.13)S 4(0.13)S 80
AMP 0 - - 128 - - - - - - -
CMI/2 -(na) -(na) 128(1)I -(na) -(na) -(na) -(na) 128(na)S -(na) -(na) 10
CMI/4 -(na) -(na) 128(1)I -(na) -(na) -(na) -(na) -(na) -(na) -(na) 00
CEF 0 - 64 32 - - - - - - -
CMI/2 -(na) 64(1)I 32(1)I -(na) -(na) -(na) -(na) 256(na)S -(na) -(na) 10
CMI/4 -(na) 64(1)I 32(1)I -(na) -(na) -(na) -(na) -(na) -(na) -(na) 00
aAntibiotics [TET tetracycline, CIP ciprofloxacin, NOR norfloxacin, KAN kanamycin, CHL chloramphenicol, ERY erythromycin, AMP ampicillin, CEF cefepime]
bBacterial strains: Escherichia coli [AG100, AG102, AG100Atet], Pseudomonas aeruginosa [PA124], Enterobacter aerogenes [CM64, EA27, EA289], Klebsiella pneumonia
[KP55], Providencia stuartii [NAE16]
cPBSS: percentage of bacteria strain on which synergism has been observed; (): FIC (Fractional Inhibitory Concentration) of the antibiotics after association
with plants extract; S: Synergy, I: Indifference; na: not applicable; The values in bold represent the cases of synergy between extract and antibiotic;
(-): >256 μg/mL
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antibiotics at their sub-inhibitory concentrations as ob-
tained in each bacterium (MIC/2 and MIC/4) [4, 5, 11]
against ten MDR phenotypes. Fractional inhibitory
concentration (FIC) was calculated as the ratio of
MICAntibiotic in combination/MICAntibiotic alone and the results
were discussed as follows: synergy (≤0.5), indifferent
(>0.5 to 4), or antagonism (>4) [26, 27]. All assays
were performed in triplicate.
Results
Phytochemical composition
The results of the phytochemical screening (Table 2)
showed that all the tested plant extracts contain polyphe-
nols, triterpenes, sterols and saponins. The other classes
of secondary metabolites were selectively distributed. Also,
the extract from M. oleifera contains all the classes of
screened secondary metabolites.
Antibacterial activity
Results of the antibacterial activities of the tested ex-
tracts alone and in some cases in the presence of
the PAβN on a panel of 19 Gram-negative bacteria
are summarized in Table 3. It appears that the ex-
tracts from P. edulis inhibited the growth of 17/19
(89.5 %) bacteria with a concentration ranged from
128 to 1024 μg/mL. The two other samples showed
selective activities, their inhibitory activity being re-
corded on 13/19 (68.4 %) and 11/19 (57.9 %) tested
bacteria for M. oleifera and X. mafaffa extracts re-
spectively. The lowest MIC value (128 μg/mL) was
Table 5 MIC (FIC) of different antibiotics in association of the extract of Passiflora edulis at MIC/2, MIC/4 against ten MDR bacteria
strains
Antibiotics Bacterial strains, MIC (μg/mL) of antibiotics in the absence and presence of the extract
Extract
concentration
PA124 AG100 AG102 AG100Atet EA27 EA289 CM64 KP55 KP63 NEA16 PBSS
(%)
CIP 0 16 0.50 0.50 - 1 1 0.50 2 - 1
CMI/2 16(1)I 0.50(1)I 0.50(1)I -(na) 2(2)I <0.50(na)S 8(16)A <0.50(na)S -(na) 1(1)I 20
CMI/4 16(1)I 0.50(1)I 0.50(1)I -(na) 4(4)A 1(1)I 64(256)A <0.50(na)S -(na) 1(1)I 10
NOR 0 128 2 1 - 4 8 4 16 - 4
CMI/2 128(1)I 2(1)I <1(na)S 128(na)S 4(1)I 4(0.50)S 64(16)A 4(0.25)S -(na) 4(1)I 40
CMI/4 128(1)I 2(1)I <1(na)S 128(na)S 16(4)I 8(1)I -(na)A 4(0.25)S -(na) 4(1)I 30
CHL 0 64 4 8 64 64 64 256 64 - 32
CMI/2 64(1)I 2(0.50)S <0.50(na)S 32(0.50)S 2(0.03)S 32(0.50)S 128(0.50)S 64(1)I -(na) 16(0.50)S 70
CMI/4 64(1)I 2(0.50)S 1(0.13)S 32(0.50)S 16(0.25)S 64(1)I 256(1)I 64(1)I -(na) 16(0.50)S 50
ERY 0 128 0.50 0.50 - 16 16 256 32 - 32
CMI/2 64(0.50)S <0.50(na)S <0.50(na)S -(na) 128(8)A 1(0.06)S 256(1)I 8(0.25)S 128(na)S 16(0.50)S 70
CMI/4 128(1)I <0.50(na)S <0.50(na)S -(na) 128(8)A 16(1)I 256(1)I 2(0.06)S 128(na)S 16(0.50)S 50
KAN 0 64 0.50 0.50 2 8 32 4 16 - 16
CMI/2 64(1)I <0.50(na)S 0.50(1)I <0.50(na)S 4(0.50)S 2(0.06)S 128(32)A 2(0.13)S -(na) 16(1)I 60
CMI/4 64(1)I <0.50(na)S 0.50(1)I 1(0.50)S 4(0.50)S 8(0.25)S -(na) 2(0.13)S -(na) 16(1)I 60
TET 0 16 32 2 64 32 32 8 2 8 32
CMI/2 8(0.50)S 16(0.50)S <0.50(na)S 8(0.13)S 64(2)I 2(0.06)S 32(4)A <0.50(na)S 4(0.50)S 8(0.25)S 80
CMI/4 16(1)I 16(0.50)S <0.50(na)S 8(0.13)S 64(2)I 4(0.13)S 64(8)A <0.50(na)S 4(0.50)S 8(0.25)S 70
AMP 0 - - 128 - - - - - - -
CMI/2 -(na) -(na) <1(na)S -(na) -(na) -(na) -(na) -(na) 256(na)S -(na) 20
CMI/4 -(na) -(na) 32(0.25)S -(na) -(na) -(na) -(na) -(na) 256(na)S -(na) 20
CEF 0 - 64 32 - - - - - - -
CMI/2 -(na) 128(2)I 8(0.25)S -(na) -(na) -(na) -(na) -(na) 128(na)S -(na) 20
CMI/4 -(na) 128(2)I 32(1)I -(na) -(na) -(na) -(na) -(na) 128(na)S -(na) 10
aAntibiotics [TET tetracycline, CIP ciprofloxacin, NOR norfloxacin, KAN kanamycin, CHL chloramphenicol, ERY erythromycin, AMP ampicillin, CEF cefepime]
bBacterial strains: Escherichia coli [AG100, AG102, AG100Atet], Pseudomonas aeruginosa [PA124], Enterobacter aerogenes [CM64, EA27, EA289], Klebsiella pneumonia
[KP55], Providencia stuartii [NAE16].
cPBSS: percentage of bacteria strain on which synergism has been observed; (): FIC (Fractional Inhibitory Concentration) of the antibiotics after association
with plants extract; S: Synergy, I: Indifference; na: not applicable; The values in bold represent the cases of synergy between extract and antibiotic;
(-): >256 μg/mL
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obtained with P. edulis and M. oleifera extracts on
Escherichia coli AG100.
Role of efflux pumps in the susceptibility of Gram-negative
bacteria
Ten of the studied MDR bacteria were also tested for
their susceptibility to the plant extracts in the presence
of the PAβN at 30 μg/mL. The results showed that when
combined with the extracts, PAβN improves the activity
(decrease of MIC values) of X. mafaffa on 4/10 (40 %) of
tested MDR strains. The EPI also improved the activity
of P. edulis against E. coli AG100 (Table 3).
Effects of the association of the extracts with antibiotics
A preleminary study was performed against P. aerugi-
nosa PA124. This allowed selection of the appropriate
sub-inhibitory concentrations of MIC/2 and MIC/4 for
further studies. All the three extracts were combined
separately with eight antibiotics (CIP, NOR, CHL, ERY,
KAN, TET, CEF and AMP) to evaluate their possible
synergetic effects. The results summarized in Tables 4, 5
and 6 showed synergic effects of the three tested extract
with most of tested antibiotics except β-lactams (CEF
and AMP). At MIC/2 of the extract from X. mafaffa,
synergistic effects were observed with 6/8 (75 %) antibi-
otics (CIP, NOR, CHL, ERY, KAN, TET) against the
tested MDR bacteria. Synergistic effects (FIC ranging
from 0.5 to 0.03) were noted with the associations of each
of the X. mafaffa, P. edulis and M. oleifera extracts and
antibiotics. Low FIC values of 0.03 were obtained with the
associations of M. oleifera extracts + ERY and M. oleifera
extract + CHL against Enterobacter aerogenes EA27.
Table 6 MIC (FIC) of different antibiotics after the association of the extract of Moringa oleifera at MIC/2, MIC/4 against ten MDR
bacteria strains
Antibiotics Bacterial strains, MIC (μg/mL) of antibiotics in the absence and presence of the extract
Extract
concentration
PA124 AG100 AG102 AG100Atet EA27 EA289 CM64 KP55 KP63 NEA16 PBSS
(%)
CIP 0 16 0.50 0.50 - 1 1 0.50 2 - 1
CMI/2 32(2)I 0.50(1)I 0.50(1)I -(na) 1(1)I 0.50(0.50)S 4(8)A <0.50(na)S -(na) 1(1)I 20
CMI/4 32(2)I 0.50(1)I 0.50(1)I -(na) 1(1)I 0.50(0.50)S 8(16)A <0.50(na)S -(na) 1(1)I 20
NOR 0 128 2 1 - 4 8 4 16 - 4
CMI/2 128(1)I 2(1)I <1(na)S -(na) 4(1)I 4(0.50)S 64(16)A 8(0.50)S -(na) 2(0.50)S 40
CMI/4 128(1)I 2(1)I <1(na)S -(na) 4(1)I 4(0.50)S 128(32)A 16(1)I -(na) 2(0.50)S 30
CHL 0 64 4 8 64 64 64 256 64 - 32
CMI/2 32(0.50)S 4(1)I 1(0.13)S 64(1)I 32(0.50)S 32(0.50)S 128(0.50)S 2(0.03)S -(na) 32(1)I 60
CMI/4 64(1)I 4(1)I 2(0.25)S 64(1)I 32(0.50)S 32(0.50)S 256(1)I 4(0.06)S -(na) 32(1)I 40
ERY 0 128 0.50 0.50 - 16 16 256 32 - 32
CMI/2 128(1)I <0.50(na)S <0.50(na)S 128(na)S 8(0.50)S 8(0.50)S 128(0.50)S 1(0.03)S 128(na)S 16(0.50)S 90
CMI/4 128(1)I <0.50(na)S <0.50(na)S 128(na)S 8(0.50)S 8(0.50)S 256(1)I 4(0.13)S 128(na)S 16(0.50)S 80
KAN 0 64 0.50 0.50 2 8 32 4 16 - 16
CMI/2 32(0.50)S <0.50(na)S <0.50(na)S <0.50(na)S 1(0.13)S 2(0.06)S 8(2)I 4(0.25)S -(na) 4(0.25)S 80
CMI/4 64(1)I <0.50(na)S <0.50(na)S 1(0.50)S 2(0.25)S 4(0.13)S 256(64)A 8(0.50)S -(na) 8(0.50)S 70
TET 0 16 32 2 64 32 32 8 2 8 32
CMI/2 16(1)I 16(0.50)S 1(0.50)S 8(0.13)S 16(0.50)S 4(0.13)S 8(1)I <0.50(na)S 4(0.50)S 8(0.25)S 80
CMI/4 16(1)I 32(1)I 1(0.50)S 8(0.13)S 16(0.50)S 4(0.13)S 64(8)A <0.50(na)S 4(0.50)S 8(0.25)S 70
AMP 0 - - 128 - - - - - - -
CMI/2 -(na) -(na) 128(1)I -(na) -(na) -(na) -(na) -(na) -(na) -(na) 00
CMI/4 -(na) -(na) 128(1)I -(na) -(na) -(na) -(na) -(na) -(na) -(na) 00
CEF 0 - 64 32 - - - - - - -
CMI/2 -(na) 64(1)I 32(1)I -(na) -(na) -(na) -(na) -(na) -(na) -(na) 00
CMI/4 -(na) 64(1)I 32(1)I -(na) -(na) -(na) -(na) -(na) -(na) -(na) 00
aAntibiotics [TET tetracycline, CIP ciprofloxacin, NOR norfloxacin, KAN kanamycin, CHL chloramphenicol, ERY erythromycin, AMP ampicillin, CEF: cefepime]
bBacterial strains: Escherichia coli [AG100, AG102, AG100Atet], Pseudomonas aeruginosa [PA124], Enterobacter aerogenes [CM64, EA27, EA289], Klebsiella pneumonia
[KP55], Providencia stuartii [NAE16]
cPBSS: percentage of bacteria strain on which synergism has been observed; (): FIC (Fractional Inhibitory Concentration) of the antibiotics after association
with plants extract; S: Synergy, I: Indifference; na: not applicable; The values in bold represent the cases of synergy between extract and antibiotic;
(-): >256 μg/mL
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Discussion
Phytochemical screening revealed the presence of several
classes of secondary metabolites such as alkaloids, poly-
phenols, flavonoids, anthraquinones, coumarins, sapo-
nins, tannins, triterpenes and steroids. Several molecules
belonging to these classes were found to be active on
pathogenic microorganisms [3, 28–30]. The presence of
such metabolites in the studied plant extracts can pro-
vide a preliminary explanation on their antibacterial
activities. Differences were observed in the antibacterial
activities of the extracts. These could be due to the dif-
ferences in their chemical composition as well as in
the mechanism of action of their bioactive constitu-
ents [3]. As shown in Table 2, all the extracts are rich
in secondary metabolites especially the extract from
M. oleifera (which contains all the tested classes);
However, activity does not depend only on the pres-
ence of secondary metabolites in the plant extracts,
but mostly on their concentration and the possible
interactions with other constituents.
To the best of our knowledge, the antibacterial activity
of X. mafaffa is being reported here for the first time.
The inhibitory activity of M. oleifera was previously re-
ported against some bacteria such as Escherichia coli,
Pseudomaonas aeruginosa, Stapylococcus aureus and
Salmonella typhii [31]. The present study confirmed the
antimicrobial potential of this plant and provide add-
itional information on it ability to inhibit the growth of
MDR bacteria.
The results of this work are very important taking in
account the medicinal importance of the tested MDR
bacteria [32–36] and also the fact that samples used are
edible plants. In the presence of PAβN (EPI), the anti-
bacterial activity of some of the extracts increased,
suggesting that some active constituents may have intra-
cellular target. In the presence of the EPI, the activity of
M. oleifera remain unchanged, indicating that the bio-
active compounds of this extract are not the substrates
of bacterial efflux pumps, as the tested MDR bacteria
over-express efflux pumps [32–36]. However, it should
be observed that in certain cases (Table 3), MIC values
of Xanthosoma mafaffa and Passiflora edulis extracts
increased in the presence of PAßN. A possible explan-
ation is that some active constituents of these extracts
may act in the cell coat, inhibiting the synthesis of pep-
tidoglycan. In such case, in the absence of PAßN, such
compounds are extruded from the cytoplasm of bacteria
by efflux pumps, then re-cross the cell membrane to
reach their target in the coat, explaining while the MIC
value is lower; in presence of PAßN, the efflux pumps
are blocked and such compounds could not be expelled
from the cytoplasm, reducing their concentration in the
cell coat and consequently their activity, explaining their
higher MIC values.
In the recent years, scientists intensified the search of
substances with ability to restore the activity of available
antibiotics to MDR bacteria. In this work, synergistic
effects were noted with the associations of X. mafaffa, P.
edulis and M. oleifera extracts and some antibiotics, pro-
viding additional information of their possible use to
combat MDR phenotypes.
Conclusion
The results of the present investigation show that X.
mafaffa, P. edulis and M. oleifera may be useful in the
control of many infectious diseases, particularly those
caused by the multidrug resistant Gram-negative bac-
teria. These extracts may be used alone or in combin-
ation with certain antibiotics such as tetracycline,
ciprofloxacin, norfloxacin, chloramphenicol, erythro-
mycin, kanamycin but not beta-lactamines. The isolation
of the active compounds from the three plants consti-
tutes the limitation of the present study and will be fur-
ther performed. Also, further investigations of the plant
extracts are warranted in vivo to validate their use for
the control of infectious diseases.
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